{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:28:57Z","timestamp":1786357737810,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["3 Biotech"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s13205-026-04930-9","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:07:22Z","timestamp":1783148842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated proteomic profiling and in silico miRNA and lncRNA analysis of glucose-capped fisetin silver nanoparticle-mediated cell proliferation arrest in breast cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"K.","family":"Subhalakshmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu Priya","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananthi","family":"Sivagnanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasankar","family":"Thangasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1357-6466","authenticated-orcid":false,"given":"Arul Prakash","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"4","key":"4930_CR1","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s12668-025-02171-3","volume":"15","author":"T Abiraamavalli","year":"2025","unstructured":"Abiraamavalli T, Namasivayam SKR, Lavanya M, Priyanka S (2025) Mechanistic Insights into the Anti-cancer Activity of Nanosulfur-Doped Zinc Oxide-Chitosan-PVA-PEG Nanocomposite in MDA-MB-231 Triple-Negative Breast Cancer Cells. BioNanoScience 15:610","journal-title":"BioNanoScience"},{"key":"4930_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109771","volume":"351","author":"H Agraval","year":"2022","unstructured":"Agraval H, Sharma JR, Prakash N, Yadav UCS (2022) Fisetin suppresses cigarette smoke extract-induced epithelial to mesenchymal transition of airway epithelial cells through regulating COX-2\/MMPs\/\u03b2-catenin pathway. Chem Biol Interact 351:109771. https:\/\/doi.org\/10.1016\/j.cbi.2021.109771","journal-title":"Chem Biol Interact"},{"key":"4930_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19937-3","volume":"8","author":"S Ananthi","year":"2018","unstructured":"Ananthi S, Lakshmi CNP, Atmika P et al (2018) Global Quantitative Proteomics reveal Deregulation of Cytoskeletal and Apoptotic Signalling Proteins in Oral Tongue Squamous Cell Carcinoma. Sci Rep 8:1567. https:\/\/doi.org\/10.1038\/s41598-018-19937-3","journal-title":"Sci Rep"},{"key":"4930_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-022-03121-6","author":"P Banthia","year":"2022","unstructured":"Banthia P, Gambhir L, Sharma A et al (2022) Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer. 3 Biotech. https:\/\/doi.org\/10.1007\/s13205-022-03121-6","journal-title":"3 Biotech"},{"key":"4930_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105110","volume":"22","author":"M Blijlevens","year":"2021","unstructured":"Blijlevens M, Li J, van Beusechem VW (2021) Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities. Int J Mol Sci 22:5110. https:\/\/doi.org\/10.3390\/ijms22105110","journal-title":"Int J Mol Sci"},{"key":"4930_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08185-1","volume":"12","author":"R Chaudhari","year":"2022","unstructured":"Chaudhari R, Nasra S, Meghani N, Kumar A (2022) MiR-206 conjugated gold nanoparticle based targeted therapy in breast cancer cells. Sci Rep 12:4713. https:\/\/doi.org\/10.1038\/s41598-022-08185-1","journal-title":"Sci Rep"},{"key":"4930_CR7","doi-asserted-by":"publisher","first-page":"e1823","DOI":"10.1038\/cddis.2015.192","volume":"6","author":"A De Cola","year":"2015","unstructured":"De Cola A, Volpe S, Budani MC et al (2015) miR-205-5p-mediated downregulation of ErbB\/HER receptors in breast cancer stem cells results in targeted therapy resistance. Cell Death Dis 6:e1823\u2013e1823. https:\/\/doi.org\/10.1038\/cddis.2015.192","journal-title":"Cell Death Dis"},{"key":"4930_CR8","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.22038\/IJBMS.2023.71125.15450","volume":"26","author":"AB Durairaj","year":"2023","unstructured":"Durairaj AB, Sivagnanam A, Monikam RA et al (2023) Deregulation of apoptotic proteins by induction of i>Dendropthae falcata\/i> (L.f.) Ettingsh plant extract in breast cancer cells: A proteome-wide analysis. Iranian Journal of Basic Medical Sciences 26:1202\u20131211. https:\/\/doi.org\/10.22038\/IJBMS.2023.71125.15450","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"4930_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108485","volume":"24","author":"P F\u00e9lix-Pi\u00f1a","year":"2023","unstructured":"F\u00e9lix-Pi\u00f1a P, Franco Molina MA, Zarate Trivi\u00f1o DG et al (2023) Antitumoral and Immunogenic Capacity of \u03b2-D-Glucose\u2014Reduced Silver Nanoparticles in Breast Cancer. Int J Mol Sci 24:8485. https:\/\/doi.org\/10.3390\/ijms24108485","journal-title":"Int J Mol Sci"},{"key":"4930_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03192-4","volume":"11","author":"E Ferrari","year":"2020","unstructured":"Ferrari E, Gandellini P (2020) Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms. Cell Death Dis 11:980. https:\/\/doi.org\/10.1038\/s41419-020-03192-4","journal-title":"Cell Death Dis"},{"key":"4930_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.biomaterials.2015.08.007","volume":"69","author":"NA Fonseca","year":"2015","unstructured":"Fonseca NA, Rodrigues AS, Rodrigues-Santos P et al (2015) Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination. Biomaterials 69:76\u201388. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.08.007","journal-title":"Biomaterials"},{"key":"4930_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3322\/caac.21863","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA et al (2024) Breast cancer statistics 2024. CA Cancer J Clin 74:477\u2013495. https:\/\/doi.org\/10.3322\/caac.21863","journal-title":"CA Cancer J Clin"},{"key":"4930_CR13","first-page":"551","volume":"49","author":"T Guo","year":"2018","unstructured":"Guo T, Dong X, Shi G (2018) In vitro and in vivo Antitumor Effects of Fisetin and Fisetin Nanopartical on Ovarian Cancer. Sichuan Da Xue Xue Bao Yi Xue Ban 49:551\u2013555","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"4930_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/21541248.2016.1232583","volume":"7","author":"RB Haga","year":"2016","unstructured":"Haga RB, Ridley AJ (2016) Rho GTPases: Regulation and roles in cancer cell biology. Small GTPases 7:207\u2013221. https:\/\/doi.org\/10.1080\/21541248.2016.1232583","journal-title":"Small GTPases"},{"key":"4930_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/fsn3.1872","volume":"9","author":"M Imran","year":"2021","unstructured":"Imran M, Saeed F, Gilani SA et al (2021) Fisetin: An anticancer perspective. Food Sci Nutr 9:3\u201316","journal-title":"Food Sci Nutr"},{"key":"4930_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/J.APT.2016.01.006","volume":"27","author":"WJ Jeyarani","year":"2016","unstructured":"Jeyarani WJ, Tenkyong T, Bachan N et al (2016) An investigation on the tuning effect of glucose-capping on the size and bandgap of CuO nanoparticles. Adv Powder Technol 27:338\u2013346. https:\/\/doi.org\/10.1016\/J.APT.2016.01.006","journal-title":"Adv Powder Technol"},{"key":"4930_CR17","doi-asserted-by":"publisher","first-page":"W409","DOI":"10.1093\/nar\/gkab297","volume":"49","author":"F Kern","year":"2021","unstructured":"Kern F, Aparicio-Puerta E, Li Y et al (2021) miRTargetLink 2.0\u2014interactive miRNA target gene and target pathway networks. Nucleic Acids Res 49:W409\u2013W416. https:\/\/doi.org\/10.1093\/nar\/gkab297","journal-title":"Nucleic Acids Res"},{"key":"4930_CR18","doi-asserted-by":"publisher","DOI":"10.1017\/jns.2022.72","volume":"11","author":"IM Krishnakumar","year":"2022","unstructured":"Krishnakumar IM, Jaja-Chimedza A, Joseph A et al (2022) Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study. Journal of Nutritional Science 11:e74. https:\/\/doi.org\/10.1017\/jns.2022.72","journal-title":"Journal of Nutritional Science"},{"key":"4930_CR19","doi-asserted-by":"crossref","unstructured":"Kumar RM, Kumar H, Bhatt T et al (2023) Fisetin in cancer: attributes, developmental aspects, and nanotherapeutics. Pharmaceuticals 16","DOI":"10.3390\/ph16020196"},{"key":"4930_CR20","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1158\/0008-5472.CAN-15-0273","volume":"75","author":"J Li","year":"2015","unstructured":"Li J, Han L, Roebuck P et al (2015) TANRIC: an interactive open platform to explore the function of lncRNAs in cancer. Cancer Res 75:3728\u20133737. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0273","journal-title":"Cancer Res"},{"key":"4930_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00772","author":"J Li","year":"2018","unstructured":"Li J, Gong X, Jiang R et al (2018) Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN\/Akt\/GSK3\u03b2 Signal Pathway. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2018.00772","journal-title":"Front Pharmacol"},{"key":"4930_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.7150\/ijms.49906","volume":"18","author":"L Li","year":"2021","unstructured":"Li L, Ye T, Zhang Q et al (2021) The expression and clinical significance of TPM4 in hepatocellular carcinoma. Int J Med Sci 18:169\u2013175. https:\/\/doi.org\/10.7150\/ijms.49906","journal-title":"Int J Med Sci"},{"key":"4930_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/bfgp\/elz002","volume":"18","author":"B Liu","year":"2019","unstructured":"Liu B, Shyr Y, Cai J, Liu Q (2019) Interplay between miRNAs and host genes and their role in cancer. Briefings in Functional Genomics 18:255\u2013266. https:\/\/doi.org\/10.1093\/bfgp\/elz002","journal-title":"Briefings in Functional Genomics"},{"key":"4930_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/carcin\/bgab005","volume":"42","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang A, Bao P-P et al (2021) MicroRNA-374b inhibits breast cancer progression through regulating CCND1 and TGFA genes. Carcinogenesis 42:528\u2013536. https:\/\/doi.org\/10.1093\/carcin\/bgab005","journal-title":"Carcinogenesis"},{"key":"4930_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2022.100138","author":"P Ma","year":"2022","unstructured":"Ma P, Seguin J, Ly NK et al (2022) Designing fisetin nanocrystals for enhanced in cellulo anti-angiogenic and anticancer efficacy. International Journal of Pharmaceutics: X. https:\/\/doi.org\/10.1016\/j.ijpx.2022.100138","journal-title":"International Journal of Pharmaceutics: X"},{"key":"4930_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s41021-021-00211-4","volume":"43","author":"T Moriwaki","year":"2021","unstructured":"Moriwaki T, Yoshimura A, Tamari Y et al (2021) PRDX1 is essential for the viability and maintenance of reactive oxygen species in chicken DT40. Genes and Environment 43:35. https:\/\/doi.org\/10.1186\/s41021-021-00211-4","journal-title":"Genes and Environment"},{"key":"4930_CR27","doi-asserted-by":"crossref","unstructured":"Patra JK, Das G, Fraceto LF et al (2018) Nano based drug delivery systems: Recent developments and future prospects. J Nanobiotechnol 16","DOI":"10.1186\/s12951-018-0392-8"},{"key":"4930_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098095","volume":"24","author":"H Schwarzenbach","year":"2023","unstructured":"Schwarzenbach H, Gahan PB (2023) Interplay between LncRNAs and microRNAs in breast cancer. Int J Mol Sci 24:8095. https:\/\/doi.org\/10.3390\/ijms24098095","journal-title":"Int J Mol Sci"},{"key":"4930_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/4215097","volume":"2022","author":"A Sivagnanam","year":"2022","unstructured":"Sivagnanam A, Shyamsundar V, Kesavan P et al (2022) 2D-DIGE-based proteomic profiling with validations identifies vimentin as a secretory biomarker useful for early detection and poor prognosis in oral cancers. J Oncol 2022:1\u201314. https:\/\/doi.org\/10.1155\/2022\/4215097","journal-title":"J Oncol"},{"key":"4930_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.inoche.2024.113004","volume":"169","author":"K Subhalakshmi","year":"2024","unstructured":"Subhalakshmi K, Veeraraghavan VP, Sivagnanam A et al (2024) Glucose-capped fisetin silver nanoparticles induced cytotoxicity and ferroptosis in breast cancer cells: a molecular perspective. Inorg Chem Commun 169:113004. https:\/\/doi.org\/10.1016\/j.inoche.2024.113004","journal-title":"Inorg Chem Commun"},{"key":"4930_CR31","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.biopha.2017.10.164","volume":"97","author":"K Sundarraj","year":"2018","unstructured":"Sundarraj K, Raghunath A, Perumal E (2018) A review on the chemotherapeutic potential of fisetin: in vitro evidences. Biomedicine & Pharmacotherapy 97:928\u2013940. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.164","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"4930_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178202","volume":"12","author":"S Suvarna","year":"2017","unstructured":"Suvarna S, Das U, Kc S et al (2017) Synthesis of a novel glucose capped gold nanoparticle as a better theranostic candidate. PLoS One 12:e0178202. https:\/\/doi.org\/10.1371\/journal.pone.0178202","journal-title":"PLoS One"},{"key":"4930_CR33","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.31557\/APJCP.2024.25.4.1169","volume":"25","author":"S Suwardjo","year":"2024","unstructured":"Suwardjo S, Gilang Permana K, Aryandono T et al (2024) Long-noncoding-RNA HOTAIR upregulation is associated with poor breast cancer outcome: a systematic review and meta analysis. Asian Pacific Journal of Cancer Prevention 25:1169\u20131182. https:\/\/doi.org\/10.31557\/APJCP.2024.25.4.1169","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"4930_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/life13020466","volume":"13","author":"P Tak\u00e1\u010d","year":"2023","unstructured":"Tak\u00e1\u010d P, Michalkov\u00e1 R, \u010ci\u017em\u00e1rikov\u00e1 M et al (2023) The role of silver nanoparticles in the diagnosis and treatment of cancer: are there any perspectives for the future? Life 13:466. https:\/\/doi.org\/10.3390\/life13020466","journal-title":"Life"},{"key":"4930_CR35","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.2217\/nnm-2017-0202","volume":"12","author":"X Tang","year":"2017","unstructured":"Tang X, Loc WS, Dong C et al (2017) The use of nanoparticulates to treat breast cancer. Nanomedicine 12:2367\u20132388. https:\/\/doi.org\/10.2217\/nnm-2017-0202","journal-title":"Nanomedicine"},{"key":"4930_CR36","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s12668-025-02180-2","volume":"15","author":"A Thirumalai","year":"2025","unstructured":"Thirumalai A, Girigoswami K, BoseD, Girigoswami A (2025) Polydopamine-Based Nanomaterials For Multifunctional Cancer Therapy. BioNanoSci 15:545","journal-title":"BioNanoSci"},{"key":"4930_CR37","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1731942","volume":"9","author":"S Van Wilpe","year":"2020","unstructured":"Van Wilpe S, Koornstra R, Den Brok M et al (2020) Lactate dehydrogenase: a marker of diminished antitumor immunity. Oncoimmunology 9:1731942. https:\/\/doi.org\/10.1080\/2162402X.2020.1731942","journal-title":"Oncoimmunology"},{"key":"4930_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canlet.2021.04.002","volume":"509","author":"J Venkatesh","year":"2021","unstructured":"Venkatesh J, Wasson M-CD, Brown JM et al (2021) LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack. Cancer Lett 509:81\u201388. https:\/\/doi.org\/10.1016\/j.canlet.2021.04.002","journal-title":"Cancer Lett"},{"key":"4930_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10549-018-4839-2","volume":"171","author":"Z Wang","year":"2018","unstructured":"Wang Z, Katsaros D, Biglia N et al (2018) High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival. Breast Cancer Res Treat 171:261\u2013271. https:\/\/doi.org\/10.1007\/s10549-018-4839-2","journal-title":"Breast Cancer Res Treat"},{"key":"4930_CR40","doi-asserted-by":"publisher","first-page":"9046","DOI":"10.1080\/21655979.2021.1993715","volume":"12","author":"X Wu","year":"2021","unstructured":"Wu X, Kong C, Wu Y (2021) Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)\/E2F transcription factor 3 (E2F3) axis. Bioengineered 12:9046\u20139057. https:\/\/doi.org\/10.1080\/21655979.2021.1993715","journal-title":"Bioengineered"},{"key":"4930_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cellsig.2018.01.013","volume":"44","author":"H Xiong","year":"2018","unstructured":"Xiong H, Yan T, Zhang W et al (2018) miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer. Cell Signal 44:33\u201342. https:\/\/doi.org\/10.1016\/j.cellsig.2018.01.013","journal-title":"Cell Signal"},{"key":"4930_CR42","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/s41388-018-0556-x","volume":"38","author":"C Xu","year":"2019","unstructured":"Xu C, Wang Y, Tu Q et al (2019) Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation. Oncogene 38:1832\u20131844. https:\/\/doi.org\/10.1038\/s41388-018-0556-x","journal-title":"Oncogene"},{"key":"4930_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00278","volume":"11","author":"P Xu","year":"2020","unstructured":"Xu P, Wu Q, Yu J et al (2020) A Systematic Way to Infer the Regulation Relations of miRNAs on Target Genes and Critical miRNAs in Cancers. Frontiers in Genetics 11:00278. https:\/\/doi.org\/10.3389\/fgene.2020.00278","journal-title":"Frontiers in Genetics"},{"key":"4930_CR44","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/1759-7714.12612","volume":"9","author":"C Yin","year":"2018","unstructured":"Yin C, Mou Q, Pan X et al (2018) MiR-577 suppresses epithelial\u2010mesenchymal transition and metastasis of breast cancer by targeting Rab25. Thorac Cancer 9:472\u2013479. https:\/\/doi.org\/10.1111\/1759-7714.12612","journal-title":"Thorac Cancer"},{"key":"4930_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/4664955","volume":"2021","author":"B Zhang","year":"2021","unstructured":"Zhang B, Wu Q, Cheng S, Li W (2021) Systematic Profiling of mRNA Splicing Reveals the Prognostic Predictor and Potential Therapeutic Target for Glioblastoma Multiforme. J Oncol 2021:1\u201315. https:\/\/doi.org\/10.1155\/2021\/4664955","journal-title":"J Oncol"},{"key":"4930_CR46","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.2147\/OTT.S198542","volume":"12","author":"X Zhao","year":"2019","unstructured":"Zhao X, Jiang M, Wang Z (2019) TPM4 promotes cell migration by modulating F-actin formation in lung cancer. Onco Targets Ther Volume 12:4055\u20134063. https:\/\/doi.org\/10.2147\/OTT.S198542","journal-title":"Onco Targets Ther Volume"},{"key":"4930_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01271-8","author":"C Zhou","year":"2023","unstructured":"Zhou C, Huang Y, Nie S et al (2023) Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent. Eur J Med Res. https:\/\/doi.org\/10.1186\/s40001-023-01271-8","journal-title":"Eur J Med Res"}],"container-title":["3 Biotech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-026-04930-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13205-026-04930-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-026-04930-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:36:21Z","timestamp":1786354581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13205-026-04930-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4930"],"URL":"https:\/\/doi.org\/10.1007\/s13205-026-04930-9","relation":{},"ISSN":["2190-572X","2190-5738"],"issn-type":[{"value":"2190-572X","type":"print"},{"value":"2190-5738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"299"}}